Provigil: Enhance Wakefulness and Cognitive Performance

Provigil

Provigil

Provigil is endorsed for managing sleepiness which is caused by sleep disorder and this tablet also has used to manage the depression symptoms like augmentation of memory and cognitive power.
Product dosage: 100mg
Package (num)Per pillPriceBuy
30$1.57$47.00 (0%)πŸ›’ Add to cart
60$1.13$94.00 $68.00 (28%)πŸ›’ Add to cart
90$0.99$141.00 $89.00 (37%)πŸ›’ Add to cart
120$0.92$188.00 $110.00 (41%)πŸ›’ Add to cart
180$0.85$282.00 $153.00 (46%)πŸ›’ Add to cart
270$0.80$423.00 $217.00 (49%)πŸ›’ Add to cart
360
$0.78 Best per pill
$564.00 $280.00 (50%)πŸ›’ Add to cart
Product dosage: 200mg
Package (num)Per pillPriceBuy
30$1.67$50.00 (0%)πŸ›’ Add to cart
60$1.22$100.00 $73.00 (27%)πŸ›’ Add to cart
90$1.07$150.00 $96.00 (36%)πŸ›’ Add to cart
120$0.98$200.00 $118.00 (41%)πŸ›’ Add to cart
180$0.91$300.00 $164.00 (45%)πŸ›’ Add to cart
270$0.86$450.00 $233.00 (48%)πŸ›’ Add to cart
360
$0.84 Best per pill
$600.00 $301.00 (50%)πŸ›’ Add to cart
Synonyms

Provigil (modafinil) is a prescription-only wakefulness-promoting agent indicated for the management of excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), and shift work sleep disorder (SWSD). Its unique mechanism of action differs from traditional stimulants, offering a favorable profile for improving daytime alertness in approved conditions. This medication promotes a state of heightened awareness without the typical euphoric highs or severe crashes associated with amphetamine-class drugs, making it a cornerstone treatment in sleep medicine and neurology. It is classified as a Schedule IV controlled substance in the United States due to its potential for dependence, and its use must be rigorously supervised by a qualified healthcare professional.

Features

  • Active Pharmaceutical Ingredient: Modafinil
  • Standard Tablet Strengths: 100 mg and 200 mg
  • Mechanism of Action: Exact mechanism unknown; believed to work by increasing dopamine in the brain by inhibiting dopamine reuptake. It also affects other neurotransmitters like norepinephrine, serotonin, and histamine.
  • Bioavailability: Rapidly absorbed, with peak plasma concentrations occurring at approximately 2-4 hours post-administration.
  • Half-life: Approximately 15 hours, supporting once-daily dosing.
  • Metabolism: Primarily hepatic, via CYP3A4/5 enzyme pathways, with subsequent renal elimination of metabolites.
  • Prescription Status: Schedule IV Controlled Substance (US), Prescription Only Medication (POM UK).

Benefits

  • Promotes significant improvement in wakefulness and reduces the propensity to fall asleep during waking hours in patients with narcolepsy.
  • Effectively combats excessive sleepiness in patients with OSA who are already receiving primary treatment with CPAP therapy.
  • Aids shift workers in maintaining alertness during their work hours, thereby improving occupational performance and safety.
  • Enhances cognitive functions such as memory, attention, and executive function in treated patient populations.
  • Provides sustained wakefulness with a lower risk of the jitteriness, anxiety, and rebound hypersomnia often associated with traditional stimulants.
  • Offers a once-daily dosing regimen for most patients, supporting treatment adherence.

Common use

Provigil is FDA-approved for three primary indications. Its most common use is in the treatment of narcolepsy, a chronic neurological disorder characterized by overwhelming daytime drowsiness and sudden attacks of sleep. It is also approved for improving wakefulness in patients with obstructive sleep apnea/hypopnea syndrome (OSAHS) whose sleepiness persists despite optimal treatment with primary therapies like continuous positive airway pressure (CPAP). Furthermore, it is indicated for the treatment of shift work sleep disorder (SWSD), which involves excessive sleepiness during scheduled work hours and insomnia during scheduled sleep times in those who work nontraditional shifts. It is crucial to note that Provigil is not a replacement for treating the underlying cause of OSA (e.g., CPAP remains essential). Off-label use for conditions like attention-deficit/hyperactivity disorder (ADHD) or fatigue associated with medical conditions may occur but is not endorsed by the manufacturer and should only be considered after a thorough risk-benefit analysis by a specialist.

Dosage and direction

The dosage of Provigil must be individualized based on the condition being treated and the patient’s response.

  • Narcolepsy or Obstructive Sleep Apnea (OSA): The recommended dose for adults is 200 mg taken orally once daily in the morning. Dosing may be initiated at 100 mg once daily for tolerance assessment and increased to 200 mg if warranted.
  • Shift Work Sleep Disorder (SWSD): The recommended dose for adults is 200 mg taken orally approximately 1 hour prior to the start of the work shift.
  • Elderly Patients: Due to the potential for decreased hepatic, renal, or cardiac function, consideration should be given to initiating therapy at a lower dose of 100 mg daily in elderly patients.
  • Patients with Severe Hepatic Impairment: A reduced dosage of 100 mg daily is recommended.
  • Administration is typically with or without food, though a consistent routine is advised. The tablet should be swallowed whole with water. Doses should not be split or crushed.

Precautions

  • Cardiovascular Issues: Patients with a history of left ventricular hypertrophy, mitral valve prolapse, or other significant cardiovascular problems should use Provigil with extreme caution, as it may increase heart rate and blood pressure. Baseline and periodic monitoring of vital signs is advised.
  • Psychiatric History: Provigil may precipitate or exacerbate symptoms of psychosis, mania, depression, or anxiety. A careful psychiatric history should be taken before initiation.
  • Dependence Potential: Although the risk is lower than with amphetamines, Provigil is a Schedule IV controlled substance with a known potential for psychological dependence. A history of drug or alcohol abuse necessitates careful monitoring.
  • Multiorgan Hypersensitivity Reactions: Rare but serious reactions, including drug rash with eosinophilia and systemic symptoms (DRESS), have been reported. Therapy should be discontinued if a rash or other signs of hypersensitivity appear.
  • Pregnancy and Lactation: Provigil is Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Modafinil and its metabolites are excreted in breast milk; a decision should be made to discontinue nursing or discontinue the drug.

Contraindications

Provigil is contraindicated in patients with known hypersensitivity to modafinil, armodafinil, or any of the inactive ingredients in the formulation. Its use is also contraindicated in patients with a history of serious or life-threatening rash associated with modafinil use.

Possible side effect

The majority of adverse reactions are mild to moderate. Common side effects (β‰₯1%) include:

  • Headache
  • Nausea
  • Nervousness
  • Anxiety
  • Insomnia
  • Dizziness
  • Diarrhea
  • Dry mouth
  • Rhinitis
  • Back pain

Less common but more serious side effects require immediate medical attention:

  • Serious rash, including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)
  • Signs of hypersensitivity or DRESS (fever, rash, lymphadenopathy, facial swelling)
  • Symptoms of psychosis (hallucinations, delusions), mania, or suicidal ideation
  • Chest pain, palpitations, or irregular heartbeat
  • Symptoms of angina

Drug interaction

Provigil is a moderate inducer of CYP3A4 and an inhibitor of CYP2C19. This can affect the metabolism of numerous concomitant medications.

  • CYP3A4 Substrates: Provigil may decrease the plasma concentrations and efficacy of drugs metabolized by CYP3A4 (e.g., cyclosporine, ethinyl estradiol, midazolam, triazolam, certain statins like simvastatin).
  • CYP2C19 Substrates: Provigil may increase the plasma concentrations of drugs metabolized by CYP2C19 (e.g., diazepam, phenytoin, propranolol, omeprazole).
  • Other CNS Agents: Concurrent use with other psychoactive drugs may produce additive effects. Caution is advised with other stimulants or medications that affect dopamine.
  • Warfarin (Coumadin): Provigil may increase the metabolism of warfarin, potentially decreasing its anticoagulant effect. Close monitoring of prothrombin time/INR is required during and after modafinil therapy.

Missed dose

If a dose is missed, it should be taken as soon as possible on the same day. However, if it is late in the day or near bedtime, the missed dose should be skipped to prevent insomnia. Do not double the next dose to make up for a missed one.

Overdose

In the event of a suspected overdose, contact a poison control center or emergency room immediately. Symptoms of overdose may include:

  • Agitation or excitation
  • Insomnia
  • Anxiety
  • Confusion
  • Tachycardia (elevated heart rate)
  • Hypertension (elevated blood pressure)
  • Tremors
  • Diarrhea
  • Hallucinations Treatment is primarily symptomatic and supportive. There is no specific antidote. Cardiovascular monitoring is essential.

Storage

Store Provigil tablets at room temperature, between 20Β°C to 25Β°C (68Β°F to 77Β°F), in a tightly closed container. Excursions are permitted between 15Β°C and 30Β°C (59Β°F and 86Β°F). Keep all medications out of the reach of children and pets. Dispose of unused medication properly via a take-back program or according to FDA guidelines; do not flush down the toilet.

Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided is not exhaustive and may not cover all possible uses, directions, precautions, interactions, or adverse effects.

Reviews

  • Clinical Consensus: Provigil is widely regarded by sleep specialists and neurologists as a first-line, highly effective pharmacological intervention for managing pathological sleepiness. Its distinct mechanism and favorable side-effect profile compared to traditional stimulants are frequently cited strengths.
  • Patient Feedback: Many patients with narcolepsy or SWSD report a transformative effect on their quality of life, describing a restoration of normal wakefulness that allows for improved work performance, social engagement, and overall daily functioning. Common criticisms among users include the high cost of the brand-name medication and the occurrence of side effects like headache or anxiety, which often subside with continued use or dose adjustment.
  • Critical Analysis: While effective, experts consistently emphasize that Provigil is a symptomatic treatment, not a cure. Its status as a controlled substance mandates careful patient selection and ongoing monitoring for misuse and psychiatric side effects. Its drug interaction profile requires vigilant medication reconciliation by the prescribing clinician.